Sodium monofluorophosphate
Common Name: |
Sodium monofluorophosphate |
IUPAC Name: |
disodium;fluoro-dioxido-oxo-?5-phosphane |
Molecular Formula: |
H2FO3P |
SMILES: |
[O-]P(=O)([O-])F.[Na+].[Na+] |
Inchi: |
1S/FH2O3P.2Na/c1-5(2,3)4;;/h(H2,2,3,4);;/q;2*+1/p-2 |
Inchi Key: |
BFDWBSRJQZPEEB-UHFFFAOYSA-L |
Cas No: |
10163-15-2 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
1 |
Egan Violations |
1 |
Muegge Violations |
3 |
Name |
Value |
Molecular Weight (g/mol) |
143.95 |
Mass (g/mol) |
143.936 |
Molar Refractivity |
10.09 |
Net Charge |
|
HBD |
6 |
HBA |
8 |
Rt Bonds |
0 |
Rings |
|
TPSA |
73.00 |
Hetero Atoms |
5 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.44 |
LogP |
0.049 |
iLOGP |
1.17 |
XLOGP3 |
-2.55 |
WLOGP |
-0.58 |
MLOGP |
-1.59 |
ESOL Log S |
-0.57 |
ESOL Solubility (mg/ml) |
109 |
ESOL Solubility (mol/l) |
0.27 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.39 |
Ali Solubility (mg/ml) |
166 |
Ali Solubility (mol/l) |
0.41 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.21 |
Silicos-IT Solubility (mg/ml) |
2.48 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-10.57 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.431 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.631 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |